MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Single-photon emission computed tomography(SPECT)"

  • 2022 International Congress

    Gerstmann-Straussler-Scheinker Syndrome Manifesting Levodopa-Responsive Parkinsonism, Levodopa-Induced Dyskinesia, and Abnormal DaT-SPECT

    S. Aradi (Tampa, USA)

    Objective: The objective of this report is to describe previously unreported features in a patient with Gerstmann-Straussler-Scheinker syndrome (GSS) due to the F198S mutation. Background:…
  • 2022 International Congress

    Correlation between 3 Tesla Brain MRI Nigrosome-1 imaging and SPECT 123I-Ioflupane in parkinsonian disorders

    A. López-Jiménez, J. álvarez-Linera, JF. Boan, I. Pareés, M. Kurtis (Madrid, Spain)

    Objective: To correlate nigrosome-1 (NG1) imaging and SPECT 123I-Ioflopane findings to determine the feasibility and diagnostic value of NG1 imaging in a real-world clinical setting.…
  • 2022 International Congress

    Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome

    R. Falconer, T. Hunter, E. Szabo, C. Brand (Alexandria, USA)

    Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…
  • 2022 International Congress

    DaTscan striatal binding ratio dynamics in mutations carriers at risk for Parkinson’s disease: A 2-year prospective study

    A. Droby, D. Atias, H. Lerman, RM. Hutchison, L. Yahimovich, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To investigate the temporal dynamics of striatal binding ratios (SBRs) among individuals with Parkinson's disease (PD)-related mutations and its' association with likelihood ratio (LR)…
  • MDS Virtual Congress 2021

    Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8-years follow-up

    A. Sánchez Rodríguez, I. Martínez Rodríguez, M. Sierra, P. Sánchez Juan, I. González Aramburu, M. Rivera Sánchez, J. Andrés Pacheco, A. Gutiérrez-González, O. Cuenca-Vera, J. Madera, A. García-Hernández, J. Infante (Santander, Spain)

    Objective: To characterize the 8-year progression of clinical and imaging biomarkers in a cohort of asymptomatic LRRK2 G2019S carriers and to assess its utility as predictors of…
  • MDS Virtual Congress 2021

    A direct longitudinal comparison of free water diffusion MRI and DaTscan SPECT in Parkinson’s Disease.

    C. Conklin, D. Scott, L. Bracoud, J. Suhy (Princeton, USA)

    Objective: To compare the within-subject longitudinal sensitivity of PD biomarkers derived from DaTscan and Diffusion MRI. Background: Parkinson’s Disease (PD) is associated with impaired striatal…
  • MDS Virtual Congress 2021

    Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

    A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: We aimed to study the association between presynaptic striatal dopamine uptake and functional connectivity (FC) patterns among healthy first-degree relatives of PD patients with…
  • MDS Virtual Congress 2021

    DAT-IQ improves power to detect longitudinal change in DaT deficit in SURE-PD3

    Z. Fan, J. Seibyl, K. Marek, M. Schwarzschild, E. Macklin, R. Gunn (London, United Kingdom)

    Objective: DATIQ has been developed as a novel analytical approach to improve the sensitivity and statistical efficiency of dopamine transporter (DaT) SPECT quantification over previously…
  • MDS Virtual Congress 2021

    EVOLUTION OF PARKINSON’S DISEASE IN PATIENTS WITH ESSENTIAL TREMOR: CLINICAL AND NEUROIMAGING ASPECTS

    G. Froehner, C. Camargo, G. Fabiani, A. Meira, H. Teive (Curitiba, Brazil)

    Objective: Analyze the result of the SPECT-TRODAT image exam in patients with ET and to evaluate the predictive value of a possible evolution to the…
  • MDS Virtual Congress 2021

    Striatal dopaminergic loss in early clinically unilateral Parkinson’s disease: a systematic review

    N. Heng, N. Malek, M. Lawton, K. Grosset, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

    Objective: To quantify the extent of dopaminergic loss in early clinically unilateral PD from studies using presynaptic dopamine imaging with either single photon emission computed tomography…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • #24752 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley